Dry Precision-Cut Amniotic Membrane Micrografts
Placental Tissue. Precisely Placed.
A-MATRX is a dry human amniotic membrane allograft supplied in a precision-cut micrograft configuration for targeted, clinician-directed placement.
- Human amniotic membrane
- Precision-cut micrografts
- Ready to use
- No pre-hydration
- Ambient storage
- Single-patient use
What is A-MATRX
Human amniotic tissue in a different geometry
A-MATRX Micrograft is a human amniotic membrane allograft derived from donated placental tissue and supplied in a dry, precision-cut micrograft configuration.
The format allows the qualified healthcare professional to distribute the tissue according to site geometry and procedural requirements, consistent with the current Instructions for Use.
A-MATRX is provided ready to use. No preparation, reconstitution or pre-hydration is required before application.
- Tissue
- Human amniotic membrane
- Configuration
- Dry precision-cut micrografts
- Preparation
- Ready to use
- Selection
- By tissue quantity
Why micrograft
Because anatomy is rarely flat
Traditional sheet allografts provide a continuous configuration across a defined area. Some sites call for a more focused and adaptable placement method.
A-MATRX gives clinicians a different tissue geometry for curved surfaces, narrow spaces, irregular tissue planes and focused areas.
- Distribute according to site geometry
- Contour across irregular surfaces
- Focus placement within the procedural field
- Select the quantity appropriate for the procedural plan
- Use from a dry configuration
- Apply directly according to the current IFU
Platform relationship
One upstream tissue platform. Two distinct final configurations.
A-MATRX is built on the EvoPatch upstream amniotic tissue preparation platform. The finished configuration, supporting evidence, use information and regulatory assessment remain product-specific.
EvoPatch
Continuous membrane sheet
- Supplied as a continuous amniotic membrane sheet
- Selected by sheet dimensions
- Positioned according to anatomy and procedural requirements
A-MATRX
Precision-cut micrografts
- Supplied as discrete, dry amniotic membrane micrografts
- Selected by tissue quantity
- Distributed by the clinician according to site geometry
Product selection should follow the current Instructions for Use, site geometry, procedural requirements and clinician judgment. This comparison does not imply that either configuration is clinically superior.
Product attributes
Prepared for controlled clinical handling
Product characteristics below are aligned to the current A-MATRX product records and controlled Instructions for Use.
Human amniotic membrane
Derived from donated human placental tissue and supplied as an allograft.
Precision-cut configuration
The finished membrane is precision-cut into discrete micrografts rather than supplied as a continuous sheet.
Dry format
Preserved and supplied in a dry configuration for clinician-directed placement.
Ready to use
No preparation, reconstitution or pre-hydration is required before application.
Sterile and single-use
Supplied sterile for one patient and one use. Do not sterilize or re-sterilize.
Ambient storage
Store at 15-30 C / 59-86 F in the conditions stated by the current IFU. Do not freeze.
Tissue traceability
Product labeling and the Allograft Tissue Usage Record support required tissue tracking.
Established configurations
Select by tissue quantity
A-MATRX commercial references are organized by tissue quantity, allowing the qualified healthcare professional and facility to select the configuration aligned with the procedural plan.
40 mg
Focused tissue quantity for clinician-directed product selection.
80 mg
Intermediate tissue quantity for clinician-directed product selection.
160 mg
Larger tissue quantity for clinician-directed product selection.
Controlled handling
Ready to use at the sterile field
Follow the current Instructions for Use, institutional protocol and aseptic technique throughout preparation and application.
- 01
Inspect
Confirm packaging integrity, label accuracy and expiration date before use.
- 02
Open
Using aseptic technique, open the outer pouch and present the contents to the sterile team member.
- 03
Transfer
Remove the graft from the inner pouch and transfer it to the sterile field.
- 04
Apply
Apply directly to cover the intended wound or surgical site as determined by the qualified healthcare professional.
- 05
Complete
Discard unused tissue after opening and complete the required allograft tissue tracking record.
Storage
15-30 C / 59-86 F
Preparation
No reconstitution or pre-hydration
Tracking
Complete the supplied usage record
FAQ
Common A-MATRX questions
What is A-MATRX Micrograft?
A-MATRX is a dry human amniotic membrane allograft supplied in a precision-cut micrograft configuration for targeted, clinician-directed placement.
How is A-MATRX different from a continuous sheet?
A continuous sheet and a precision-cut micrograft configuration provide different placement geometries. A-MATRX allows the clinician to distribute the tissue according to site geometry and procedural requirements, consistent with the current Instructions for Use.
How is A-MATRX related to EvoPatch?
A-MATRX is built on the EvoPatch upstream amniotic tissue preparation platform, but it has a different final configuration. A-MATRX is supplied as dry, precision-cut micrografts rather than as a continuous membrane sheet.
Does A-MATRX require preparation or pre-hydration?
No. The current Instructions for Use state that A-MATRX requires no preparation, reconstitution or pre-hydration before use.
What configurations are established?
Established commercial references include 40 mg, 80 mg and 160 mg configurations. Contact Evologics to confirm current availability and ordering information.
Does A-MATRX require refrigeration?
A-MATRX is stored at 15-30 C / 59-86 F according to the current Instructions for Use. Do not freeze.
Is A-MATRX reusable?
No. A-MATRX is supplied for single-patient, single-use application. Unused tissue must be discarded after opening.
Where can my facility request product documentation?
Evologics can provide current product information, Instructions for Use, ordering details and facility-review documentation through the Request Information form.
Use and product information
A-MATRX is a human tissue allograft intended for use by qualified healthcare professionals in accordance with the current Instructions for Use and applicable institutional requirements.
Product selection, preparation, placement and documentation remain the responsibility of the qualified healthcare professional and facility.
The current Instructions for Use and product labeling govern if any website description differs from the controlled product documents.
A-MATRX
Request A-MATRX information for your facility.
Connect with Evologics for current product materials, established configurations, Instructions for Use, facility-review documentation and ordering information.